DNA methylation signatures of diseases
Q&A: Coffee break with TRANSFAC
This event was held on October 29th, 2024
FREE online seminar
Seminar Description
In this webinar Dr. Alexander Kel, the CEO and CSO of geneXplain GmbH, will provide a general introduction into epigenomics and will analyze ATAC-seq data of BPTF knockouts in Acute Myeloid Leukemia (AML) (GSE226670) and ChIP-seq and CUT&RUN data of FOXO1 knockouts in diffuse large B-cell lymphoma (DLBCL) (GSE254405) for enriched transcription factor binding sites, composite modules and upstream regulators, via combined promoter and pathway analysis with TRANSFAC master-regulators and Genome Enhancer.
In this webinar Prof. Dr. Alexander Kel, the CEO and CSO of geneXplain GmbH, will address the exciting topic of DNA methylation changes observed in various pathologies with a focus on DNAm signatures of Kabuki syndrome and CHARGE syndrome – two rare genetic diseases belonging to the family of chromatinopathies. Alexander will demonstrate how DNA methylation data analysis in the geneXplain platform and Genome Enhancer tool can reveal unique patterns of DNAm alterations specific for the studied pathology, and how mutual DNAm changes in two different pathologies can be identified, potentially explaining some of the shared symptoms between the two different pathological conditions.
The following main topics will be in the focus of this webinar:
What you will learn in this webseminar
Seminar Schedule
The session started on October 29th at 6 PM CET with a lecture from Prof. Dr. Alexander Kel (approx. 1 hour) and was continued with a Q&A session addressing the questions coming from the attendees of the online event (up to 30 minutes).
Information resources
What You Get
What others say about our educational programs and software
The Lecturer
Prerequisites
Basic knowledge of biochemistry and molecular biology. No programming skills are required.
Previous webseminar on model organisms
To Whom It Might Be Interesting
FAQ
Ask Your Question
[fluentform id=”17″]